|
|
||||||||
1 Laboratory of Exercise Physiology, Division of Health Promotion and Exercise, National Institute of Health and Nutrition, 1-23-1 Toyama, Shinjuku City, Tokyo 162-8636; 2 Department of Physiology and Biomechanics, National Institute of Fitness and Sports, Kanoya City, Kagoshima Prefecture, 891-2393; and 3 Department of Sports Sciences, School of Human Sciences, Waseda University, Tokorozawa City, Saitama Prefecture, 359-1192, Japan
| |
ABSTRACT |
|---|
|
|
|---|
The
purpose of the present investigation was to establish a method for
estimating intracellular Ca2+ concentrations
([Ca2+]i) in isolated rat epitrochlearis
muscles. Epitrochlearis muscles excised from 4-wk-old male
Sprague-Dawley rats were loaded with a fluorescent Ca2+
indicator, fura 2-AM, for 60-90 min at 35°C in oxygenated
Krebs-Henseleit buffer. After fura 2 loading and subsequent 20-min
incubation, the intensities of 500-nm fluorescence, induced by 340- and
380-nm excitation lights (Ftotal340 and
Ftotal380), were measured. The fluorescences specific
to fura-2 (Ffura 2340 and Ffura 2380) were
calculated by subtracting the non-fura 2-specific component from
Ftotal340 and Ftotal380, respectively. The
ratio of Ffura 2340 to Ffura 2380 was
calculated as R, and the change in the ratio from the baseline value
(
R) was used as an index of the change in
[Ca2+]i. In resting muscle,
R was stable
for 60 min. Incubation for 20 min with caffeine (3-10 mM)
significantly increased
R in a concentration-dependent manner.
Incubation with hypoxic Krebs-Henseleit buffer for 10-60 min
significantly elevated
R, depending on the duration of the
incubation. Incubation with 50 µM
N-(6-aminohexyl)-5-chloro-1-naphthalenesulfonamide for 20 min significantly elevated
R (P < 0.05). No
significant increases in
R were observed during incubation for 20 min with 2 mM
5-aminoimidazole-4-carboxamide-1-
-D-ribofuranoside or
with 2 mU/ml insulin. These results demonstrated that, by using the fura 2-AM fluorescence method, the changes in
[Ca2+]i can be monitored in the rat
epitrochlearis muscle and suggest that the method can be utilized to
observe quantitative information regarding
[Ca2+]i that may be involved in contraction-
and hypoxia-stimulated glucose transport activity in skeletal muscle.
fura 2; hypoxia; 5-aminoimidazole-4-carboxamide-1-
-D-ribofuranoside; insulin; caffeine; intracellular Ca2+ concentration
| |
INTRODUCTION |
|---|
|
|
|---|
IN MAMMALIAN SKELETAL MUSCLE, intracellular free calcium (Ca2+) has been assumed to play important roles not only in excitation-contraction coupling (31) but also in signal transduction as a second messenger modulating a variety of essential cellular functions (2, 14).
Generally, the intracellular Ca2+ concentration ([Ca2+]i) is estimated with fluorescent Ca2+ indicators, such as fura 2 and indo 1. Previous investigations using these fluorescent Ca2+ indicators developed methods for measuring [Ca2+]i in mammalian skeletal muscle (4, 5, 24, 26, 39, 40) or cultured muscle (15, 30, 42) cells. Although these previous investigations using frog skeletal muscle and cultured skeletal muscle cells provided valuable information on Ca2+ in skeletal muscles, [Ca2+]i in intact mammalian muscle must be measured if we are to evaluate the role of Ca2+ concentration in skeletal muscle, because frog skeletal muscle and cultured cells may have different characteristics from mammalian skeletal muscle cells. These differences include the lack of additivity of the maximal effect of insulin and the contraction on glucose transport activity (22), the requirement of protein synthesis for the reversal of enhanced glucose transport activity after contraction (17) in frog sartorius muscle, the absence of sarcoplasmic reticulum (SR) from myoblasts (16), or the low expression levels of the GLUT-4 isoform of the glucose transporter in cultured cells (16). Tòth et al. (43) established a method to assess [Ca2+]i levels in rat skeletal muscle in vivo. However, no method for measuring [Ca2+]i in rat skeletal muscle in vitro has yet been reported. For the purpose of studying the effects of the combination of various physiological and pharmacological stimuli on [Ca2+]i and its involvement in glucose transport activity in rat skeletal muscle, an in vitro method for assessing [Ca2+]i in isolated rat muscle is necessary.
Because Ca2+ has been postulated to be involved in enhanced glucose transport stimulated by contraction and/or hypoxia (23), several previous investigations (10, 45, 46) adopted in vitro pharmacological approaches using pharmacological stimulators [caffeine, N-(6-aminohexyl)-5-chloro-1-naphthalenesulfonamide (W-7)] or inhibitors (dantrolene, 9-aminoacridine) of Ca2+ release from SR and evaluated the effects of the postulated changes in Ca2+ on glucose transport activity in rat epitrochlearis muscle. The epitrochlearis muscle is a thin muscle only ~20 fibers thick (34). This short diffusion distance makes it possible to maintain adequate ATP and creatine phosphate levels during prolonged incubation in vitro (32). A number of studies of glucose transport have demonstrated the suitability of the epitrochlearis muscle for in vitro incubation experiments (7, 10, 45-47). Therefore, because this muscle in oxygenated incubation medium in vitro is known to maintain its physiological functions similar to those under an in vivo condition for a long time, we thought it would be possible to monitor the changes in [Ca2+]i in rat epitrochlearis muscle in vitro by using a fluorescent Ca2+ indicator.
In terms of glucose transport, hypoxia stimulates glucose transport activity in skeletal muscles (7, 10, 46), as do insulin and contraction. Although the mechanism underlying hypoxia-stimulated glucose transport has not yet been determined, one candidate for this mechanism is the increase in [Ca2+]i (7, 10, 46). However, no report has observed the actual involvement of Ca2+ in hypoxia-stimulated glucose transport, because no technique for monitoring the change in [Ca2+]i in the rat epitrochlearis muscle has been established. Such a technique would be a valuable tool for evaluating the role of [Ca2+]i in regulating glucose transport in skeletal muscle.
Therefore, the purposes of the present investigation were 1) to establish a method for monitoring changes in [Ca2+]i in the rat epitrochlearis muscle by using the fluorescent indicator techniques, and, 2) using the new method, to assess the effect of several physiological (hypoxia) and pharmacological stimuli on [Ca2+]i in rat skeletal muscle.
| |
MATERIALS AND METHODS |
|---|
|
|
|---|
Materials. Fura 2-AM was purchased from Molecular Probes (Eugene, OR). All other biochemicals were purchased from Sigma Chemical (St. Louis, MO).
Animals and muscle preparation. Male Sprague-Dawley rats (Kyudo, Kumamoto, Japan), each weighing 110-120 g, were used. All the animals were housed in rooms lighted from 7 AM to 7 PM and were maintained with ad libitum feeding on standard chow and water. The room temperature was maintained at 20-22°C. Food was restricted to 8 g on the evening of the last day before the experiment.
The rats were anesthetized with an intraperitoneal injection of pentobarbital sodium, 5 mg/100 g body wt, and the epitrochlearis muscles were dissected out. The muscles weighed ~10-15 mg (wet weight) and averaged ~1.0 cm in length, 0.4 cm in width, and <0.2 mm in thickness (34). Approximately 80-85% of the epitrochlearis muscle fibers are composed of fast-twitch (type II) fibers (34). After dissection, the muscles were allowed to recover for >60 min in 25-ml stoppered Erlenmeyer flasks containing 3 ml oxygenated Krebs-Henseleit bicarbonate buffer (KHB) with 8 mM glucose and 32 mM mannitol. The gas phase in the flasks during the recovery period was 95% O2-5% CO2 at 35°C.Fura 2 loading. For fura 2 loading, the acetoxymethyl ester form of fura 2 (fura 2-AM) was used because it has the following properties: 1) Fura 2-AM is shown to be loaded into muscle cells easily in its cell-permeable AM form, which is deesterified by esterases in the cytoplasm. 2) Fura 2 alters its excitation spectrum on binding to Ca2+. If we excite fura 2 by using two alternating wavelengths of light (typically 340 and 380 nm) while monitoring emissions near 500 nm, the ratio of fluorescence intensities at the two excitation wavelengths provides a measure of the [Ca2+]i independently of the dye concentration (19).
First, fura 2-AM was dissolved in DMSO in a 2 mg/ml concentration, added to KHB to make a final concentration of 10 µM, and then mixed vigorously by applying ultrasonic waves. A noncytotoxic detergent, 0.02% Cremophor EL, was added to increase the solubility of the fura 2-AM (1). The epitrochlearis muscles were incubated for 60-90 min at 35°C in 25-ml stoppered Erlenmeyer flasks containing 1.5 ml KHB with fura 2-AM. Because fura 2-AM is sensitive to light, the flasks were wrapped in aluminum foil. The gas phase in the flasks during the fura 2-AM loading period was 95% O2-5% CO2.Fluorescence measurement.
The fluorescence from the epitrochlearis muscle was measured with a
fluorometer specially designed to measure the fluorescence of living
tissues (CAF-110, Japan Spectroscopic, Tokyo, Japan) (Fig.
1) (37). Because previous
studies showed that skeletal muscle tissue has a substantial amount of
endogenous NADH, whose fluorescence has similar excitation and emission
characteristics as that of fura 2-AM (1, 12, 13, 32, 37,
40), the fluorescence measured from fura 2-loaded muscle is
thought to be a sum of fura 2-derived fluorescence and a non-fura 2 component of the pyridine nucleotides. Therefore, the fluorescence
specific to fura 2 (Ffura 2340 and
Ffura 2380) was calculated as the difference between the
fluorescence intensities from fura 2-loaded muscle
(Ftotal340 and Ftotal380) and those from fura 2-free muscle (Ffura-free340 and
Ffura-free380). To obtain Ftotal340 and
Ftotal380, one epitrochlearis muscle from a rat was used. The other epitrochlearis muscle from the same rat was used for the
measurement of Ffura-free340 and
Ffura-free380. The difference in the two measurements
was the fura 2-AM loading before the fluorescence measurement. To
measure fluorescence, the muscle was held horizontally in a
temperature-controlled organ bath filled with 5 ml oxygenated KHB. The
proximal end of the muscle was connected to an isometric transducer
(TB-651t, Nihon Kohden, Tokyo, Japan) to monitor muscle tension. The
resting tension was adjusted to 5 × 10
3 N. The
muscle was then incubated in the oxygenated KHB for 20 min at 35°C to
remove unhydrolyzed fura 2-AM and to allow recovery from the stress
incurred during the setting up. During the 20-min recovery period, 8 mM
glucose were supplied with KHB to provide an energy supply for the
muscles. The fura 2-free muscles were also incubated for 20 min by use
of the same procedure as that for the fura 2-loaded muscles.
|
Experimental protocol. Experiment 1 was performed to confirm that fura 2-AM was successfully loaded into the rat epitrochlearis muscle. After fura 2-AM loading and 20 min of recovery in the organ bath, the muscles were incubated for 5 min with physiological saline containing 5 mM MnCl2 and 100 nM ionomycin. To avoid the precipitation of calcium in KHB by MnCl2, physiological saline was used for this specific experiment. The use of saline for incubating rat skeletal muscle with MnCl2 was previously validated by Tòth et al. (43). Ionomycin transports extracellular manganate ion (Mn2+) into cells (19). Mn2+ is used because the ion is known to bind to the fura 2 molecule and abolish the fluorescence emitted from fura 2 by transforming the fura 2 molecule (19). A stock solution of ionomycin was prepared in DMSO. MnCl2 and the stock solution of ionomycin were dissolved directly into physiological saline.
In experiment 2, the kinetics of Ffura 2340 and Ffura 2380 were evaluated. The ratio of Ffura 2340 to Ffura 2380 was calculated as R, and the change in the ratio from the baseline value (
R) was used as
an index of the change in [Ca2+]i.
Fluorescence was measured every 10 min during the 90-min incubation with oxygenated KHB containing 8 mM glucose and 32 mM mannitol without
interventions, and
R was calculated. At each time point, excitation
was restricted to a short period (5 s) to avoid photobleaching of the
fura 2-AM (6, 32) and to minimize the cytotoxic effect of
the ultraviolet light (32).
In experiment 3, we observed the responses of
R to
pharmacological stimuli that are known to alter
[Ca2+]i in skeletal muscle. First, the
muscles were incubated for 20 min with KHB containing 1, 3, 5, and 10 mM caffeine, which is known to release Ca2+ from SR
(36). Fluorescence was measured every 5 min, and the caffeine dose response and
R were evaluated. Second, the effect on
R of dantrolene, which is known to inhibit the release of Ca2+ from the SR in skeletal muscle (44), was
observed. Muscles were incubated with 10 mM caffeine together with 25 µM dantrolene. Fluorescence was measured every 5 min for 20 min.
Third, muscles were incubated for 20 min with 10 µM ionomycin, which
transports extracellular Ca2+ into the cell
(29). Fluorescence was measured every 5 min.
The purpose of experiment 4 was to establish the
relationships between each of various stimuli that have been known to
elevate glucose transport and
R. First, we observed the effect of
hypoxia and subsequent reoxygenation on
R. The effect of the
duration of hypoxia on
R was evaluated by measuring the fluorescence
every 10 min during a 60-min hypoxia, which was induced by incubating the epitrochlearis muscle in KHB gassed with 95% N2 and
5% CO2. To observe the effects of the different durations
of reoxygenation on the [Ca2+]i of the
previously hypoxic muscle,
R was calculated for the epitrochlearis
muscles that were first exposed to hypoxic KHB for 10-30 min,
followed by 10, 20, and 30 min incubation in the oxygenated KHB for
reoxygenation of the muscle. Furthermore, we assessed the effect of
dantrolene on
R during hypoxia. Muscles were incubated with the
hypoxic KHB containing 25 µM dantrolene for 20 min. Fluorescence was
measured every 5 min. Second, the muscles were incubated for 20 min
with KHB containing 50 µM W-7, which was first developed as a
calmodulin antagonist. This concentration of W-7 is known to induce the
release of Ca2+ from the isolated SR and to increase
glucose transport activity in rat epitrochlearis muscle without
decreases in high-energy phosphates and without visible tension
development (46). The effect of 25 µM dantrolene on
R
during incubation with W-7 was also observed for 20 min. Third, we
observed the effect of
5-aminoimidazole-4-carboxamide-1-
-D-ribofuranoside (AICAR), an AMP-activated protein kinase (AMPK) activator. AICAR has
been implicated in the stimulation of glucose transport through a
mechanism similar to exercise/contraction (20). Muscles
were incubated for 20 min with KHB containing 2 mM AICAR. Finally, muscles were incubated for 20 min with KHB containing 2 mU/ml insulin
and 0.1% radioimmunoassay-grade bovine serum albumin. This
concentration of insulin is known to maximally stimulate glucose
transport in rat skeletal muscle (11).
Data analyses.
The R value was calculated as
Ffura 2340/Ffura 2380. In addition, the
change in [Ca2+]i during each treatment was
evaluated by observing the alteration of the
R value, which was
calculated as the difference between the pretreatment value of R and R
at the specific time point of treatment. The pretreatment of R was
defined as the value observed immediately before each treatment that
started at least 20 min after the muscle was set in the organ bath
circulated by the oxygenated KHB.
Statistics. All values were expressed as means ± SD. In experiment 1, statistical analysis was performed using a two-way ANOVA (Jandel Sigma Stat, Jandel, San Rafael, CA) to examine the effects of the fura-2 loading and MnCl2 + ionomycin incubation (fura 2 × MnCl2). Repeated measurement of one-way ANOVA was used to evaluate the statistical significance in experiments 2 and 4. For analyzing the effects of caffeine concentration and incubation time (treatment × time), two-way ANOVA was performed in experiment 3. In all experiments, whenever the ANOVA indicated significant differences, the Tukey test was used for post hoc analysis. Statistical significance was defined as P < 0.05.
| |
RESULTS |
|---|
|
|
|---|
Experiment 1.
Ffura-free340 and Ffura-free380 were
approximately one-half of Ftotal340 and
Ftotal380, respectively (Table
1) (P < 0.001). Ftotal340 and Ftotal380 after 5-min incubation
with 5 mM MnCl2 and 100 nM ionomycin was reduced to a
similar level that was not statistically different from
Ffura-free340 and Ffura-free380, respectively,
after the incubation with the same medium. Neither Ffura-free340 nor Ffura-free380 was affected by
5 min incubation with 5 mM MnCl2 and 100 nM ionomycin
|
Experiment 2.
Whereas both Ffura 2340 and Ffura 2380
decreased with time (Fig. 2A),
R was stable for 60 min (Fig. 2B). However, after 70 min,
R increased significantly (P < 0.01).
|
Experiment 3.
Incubation with 1 mM caffeine did not affect
R (Table
2). Incubation with 3, 5, and 10 mM
caffeine increased
R significantly (P < 0.05, 0.01, and 0.001, respectively). The increment in
R during the 20-min
incubation with 10 mM caffeine was significantly greater than the
increments observed during the 3 and 5 mM caffeine incubations
(P < 0.05), whereas no significant difference in
R was observed between the 3 and 5 mM caffeine incubations.
|
R.
Incubation for 20 min with 10 µM ionomycin elevated
R (Table 2)
(P < 0.001). This increase in
R was significantly
greater than that observed in 10 mM caffeine-treated muscle
(P < 0.001).
Experiment 4.
Hypoxia for 10 min in vitro resulted in a significant increase in
R
(P < 0.05). Hypoxia for 60 min induced a further
increase in
R (P < 0.01) (Fig.
3). The increased
Rs that were induced by 10 min and 20 min of hypoxia returned completely to the baseline value after 10 and 15 min of reoxygenation, respectively (Fig. 4). The 30 min hypoxia-induced increase
in
R also returned to the baseline value after 30 min of
reoxygenation. However, it was still significantly higher after 20 min
of reoxygenation (P < 0.05). As shown in Fig.
5, 25 µM dantrolene completely blocked the hypoxia-induced increment in
R.
|
|
|
R
(P < 0.05). The increase in
R after W-7 incubation
was completely blocked by incubation with 25 µM dantrolene (Fig.
6).
|
R was observed during incubation for 20 min with 2 mM
AICAR nor with 2 mU/ml insulin.
|
| |
DISCUSSION |
|---|
|
|
|---|
The present investigation demonstrated that, by using the fura 2-AM ratiometric fluorescence method, changes in [Ca2+]i within the physiological range can be monitored in the rat epitrochlearis muscle. Furthermore, and to be more specific, the method revealed the [Ca2+]i in the rat epitrochlearis muscle during hypoxia and subsequent reoxygenation. The result also demonstrated that insulin and AICAR have no effect on [Ca2+]i in rat skeletal muscle in vitro.
The calculated values of Ffura 2340 and Ffura 2380 that represent the fluorescence specific to fura-2 were as great as Ffura-free340 and Ffura-free380 (Table 2). Furthermore, both Ftotal340 and Ftotal380 were reduced to the similar respective levels as were Ffura-free340 and Ffura-free380 (Table 1) by incubation with 5 mM MnCl2, which is known to abolish fluorescence from fura 2 (19). In other words, MnCl2 virtually quenched the fluorescence specific to fura 2. Therefore, these findings suggest that fura 2-AM was loaded into the rat epitrochlearis muscle and that Ffura 2340 and Ffura 2380 represented fluorescence specific to fura 2.
In agreement with the results of previous investigations (3, 40,
42), the pretreatment values of R observed in the present
investigation varied substantially from preparation to preparation.
Although the reason for this variation remains unknown, it seemed
plausible that, in some muscles, a portion of fura 2-AM may enter SR
and mitochondria, which contain large amounts of Ca2+
(27, 32). Therefore, in previous studies (28, 35,
40), not R but the
R value was used as an index of the change
in [Ca2+]i during a treatment. In the present
investigation, we also used
R as an index of the change in
[Ca2+]i during each treatment in the rat
epitrochlearis muscle.
R was stable for 60 min during the resting condition, whereas a
significant decrease was observed in both Ffura 2340 and
Ffura 2380. However, after 70 min,
R significantly increased (Fig. 2-B). This result suggests that fluorometric
measurement of [Ca2+]i in rat epitrochlearis
muscle in the present investigation is not reliable beyond 60 min. The
possible reasons for the increase in
R after 70 min of incubation
may be hydrolization, photobleaching, and decomposition of fura 2 during prolonged incubation (6, 38). Because Sato et al.
(37) also concluded that fluorometric experiments on
smooth muscle should be terminated within 60 min, incubation was also
limited to 60 min in the present investigation.
In the present investigation,
R had the following characteristics
(Table 2): 1)
R increased in response to caffeine
(3-10 mM) in a concentration-dependent manner. 2)
Dantrolene (25 µM) completely abolished the response of
R to
incubation with 10 mM caffeine. 3)
R was elevated by
Ca2+ ionophore (10 µM ionomycin) four times more than by
10 mM caffeine. These observations certify that, by using
R, the
changes in [Ca2+]i induced by various
pharmacological stimuli can be monitored in the rat epitrochlearis muscle.
Incubation of the epitrochlearis muscle with a hypoxic medium has been used to evaluate hypoxia-induced increases in glucose transport activity in skeletal muscle (7, 10, 46). Although previous investigations suggested that the elevation of [Ca2+]i might be involved in the mechanism related to in vitro hypoxia-stimulated glucose transport (7, 10, 46), until now no report has observed actual changes in [Ca2+]i in skeletal muscle during in vitro hypoxia. Using fluorometry of fura 2, the present investigation is the first to observe the effect of in vitro hypoxia on [Ca2+]i in skeletal muscle tissue.
In terms of glucose transport in skeletal muscle, because the maximal
effects of in vitro hypoxia and muscle contraction were not additive
(10), hypoxia was thought to stimulate glucose transport
activity by the same pathway as muscle contraction. Although the
mechanism by which hypoxia stimulates glucose transport is not known,
the involvement of elevated [Ca2+]i after
hypoxia has been suggested as a possible candidate (7, 10,
46). The present investigation showed that incubation for
10-20 min under a hypoxic condition resulted in significant increases in
R, a finding that suggests that
[Ca2+]i does increase during in vitro
hypoxia. Furthermore, a sustained elevation of
R (~0.20) was
observed during 60 min of hypoxia.
When the glucose transport activity induced by submaximal (20 min) and
maximal (60 min) durations of hypoxia was estimated, the activity had
been actually measured after 15 min of reoxygenation, during which the
ATP and creatine phosphate in the muscle were shown to recover
(10, 41). The present investigation demonstrated that the
elevated
R after 10- to 20-min hypoxia returned to the prehypoxia
value after 15 min of reoxygenation. However, when the duration of
hypoxia was prolonged to 30 min,
R did not recover to the
pretreatment value after the same duration (15 min) of reoxygenation
(Fig. 4). These results demonstrate that the longer the hypoxia, the
more time it takes to restore [Ca2+]i
afterward. Furthermore, the findings of the present investigation demonstrated that the glucose transport activity after 20-min hypoxia
was measured without the elevation of
[Ca2+]i. However, the results of this
investigation also suggest that the glucose transport activity, which
was measured by the normal procedure (15-min reoxygenation after 60-min
hypoxia), and which is considered to represent the effects of 60-min
hypoxia, might be measured in the condition with elevated
[Ca2+]i (10). The involvement of
[Ca2+]i in hypoxia-stimulated glucose
transport in skeletal muscle has not yet been clarified. Furthermore,
it is not known whether elevated glucose transport activity is a direct
and short-lived effect of elevated [Ca2+]i or
an indirect and long-lived effect of a prior transient elevation of
[Ca2+]i, for example, an aftereffect of
calcium-dependent protein activation. If one attributes the
hypoxia-stimulated glucose transport activity to a
Ca2+-related mechanism, the results of the present
investigation suggest that maximal hypoxia-stimulated glucose
transport activity, normally measured after 15-min reoxygenation after
60-min hypoxia, might be regarded as a consequence of the direct
effects of the sustained elevation of [Ca2+]i
and the indirect biochemical effects related to the proceeding hypoxia-induced elevation of [Ca2+]i.
However, as described above, only speculative discussion regarding hypoxia-stimulated glucose transport activity in rat skeletal muscle is
available to date. We believe that, for the purpose of clarifying the
relation between the hypoxia-induced increase in
[Ca2+]i and the hypoxia-stimulated glucose
transport activity in rat skeletal muscle, information on
[Ca2+]i, measured by using the method
established in the present investigation, will be valuable
[Ca2+]i of epitrochlearis muscle did not change as a result of incubation with the maximal insulin dose (2 mU/ml) in terms of glucose transport activity. This result may suggest that insulin does not stimulate glucose transport through elevating [Ca2+]i. However, Bruton et al. (8) recently reported that, although insulin had no effect on the global myoplasmic Ca2+ concentration measured with a fluorescent indicator indo 1, the insulin-induced increase in [Ca2+] close to the membrane was observed by using the membrane-associating form of indo 1, FIP-18. Because a majority of fura 2 molecules in skeletal muscle fiber have been shown to be bound to relatively immobile myoplasmic constituents (25), fluorescence signals obtained from fura 2-loaded rat epitrochlearis muscle might not detect any change in membrane [Ca2+] but, instead, reflect the global free myoplasmic Ca2+ concentration, as with indo 1. Further studies are needed to examine the actual role and importance of insulin-mediated increases in membrane [Ca2+] in rat epitrochlearis muscle by using the membrane-permeable form of FIP-18.
The present investigation demonstrates that AICAR, which is known to
activate AMPK, does not alter the [Ca2+]i.
This finding suggests that changes in calcium concentration are not
involved in the mechanism related to the enhancement of glucose
transport activity by AMPK activation. AMPK activation and elevated
[Ca2+]i during muscle contraction have been
postulated to mediate the contraction-induced increase in glucose
transport activity (20, 45). Recently, Mu et al.
(33) demonstrated that the stimulation of glucose
transport was only partially blocked in electrically stimulated
contracting muscle from mice expressing a kinase-inactive
-2
catalytic subunit of AMPK. The authors concluded that an
AMPK-independent pathway must, in part, mediate the effect of
contraction on glucose uptake in muscle. In this regard, the results
of the present investigation might suggest that some portion of
the enhanced glucose transport activity by contraction is
induced by the calcium-independent pathway of AMPK activation.
Furthermore, in the present investigation, a significant increase in
R was observed during incubation with a low concentration of W-7
that was reported to stimulate glucose transport activity in rat
epitrochlearis muscle without decreases in high-energy phosphates and
visible tension development (45). These findings,
including the results of the present investigation, may suggest that
the contraction-induced increase in glucose transport activity is
mediated separately by the activation of AMPK and the increase in
[Ca2+]i. However, up to now, there has been
no direct evidence that elevated [Ca2+]i is
involved in the contraction-stimulated glucose transport. Therefore,
extensive studies are needed to further elucidate the complete
mechanism underlying muscle contraction-stimulated glucose transport activity.
Monitoring [Ca2+]i during skeletal muscle fiber contraction by using a fluorescence indicator has been shown to be sensitive to the changes in optical density induced by the tissue movement (9, 43). Also, in the present investigation, because of the movement of the epitrochlearis muscle during electrically stimulated muscle contraction, we could not measure, with certainty, the changes in [Ca2+]i in response to the twitch and tetanic contraction of rat epitrochlearis muscle. Although Carroll et al. (9) suggested that stabilization of rat skeletal muscle fibers in agarose gel suspension is useful for excluding the movement of muscle during contraction, it is unknown whether the agarose gel suspension is applicable to rat epitrochlearis muscle. Future extensive studies are needed to establish a method for successfully monitoring [Ca2+]i during muscle contraction in rat epitrochlearis muscle. Such a method would be a valuable tool for clarifying the mechanism of contraction-stimulated glucose transport activity in skeletal muscle.
In conclusion, the present investigation demonstrates that the physiological response of [Ca2+]i in the rat epitrochlearis muscle to both pharmacological and physiological stimuli can be monitored by using the fluorometric method developed in the present investigation. Furthermore, the present investigation also suggests that the method will be valuable for studying the mechanism of the enhanced glucose transport activity of skeletal muscle in vitro.
| |
ACKNOWLEDGEMENTS |
|---|
We thank Dr. Yasuo Watanabe (Department of Pharmacology, Tokyo Medical College, Tokyo, Japan) for valuable suggestions and discussion.
This work was supported by a Grant-in-Aid for Scientific Research (B) No. 09480017 (to I. Tabata) from the Japanese Ministry of Education, Science, Sports and Culture, and by a Grant-in-Aid for Scientific Research from National Institute of Fitness and Sports (to I. Tabata).
| |
FOOTNOTES |
|---|
Address for reprint requests and other correspondence: I. Tabata, Laboratory of Exercise Physiology, Division of Health Promotion and Exercise, National Institute of Health and Nutrition, 1-23-1 Toyama, Shinjuku City, Tokyo 162-8636 Japan (E-mail: tabata{at}nih.go.jp).
The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
First published January 24, 2003;10.1152/japplphysiol.00780.2002
Received 26 August 2002; accepted in final form 2 January 2003.
| |
REFERENCES |
|---|
|
|
|---|
1.
Abe, A,
and
Karaki H.
Effect of forskolin on cytosolic Ca2+ level and contraction in vascular smooth muscle.
J Pharmacol Exp Ther
249:
895-900,
1989
2.
Berchtold, MW,
Brinkmeier H,
and
Muntener M.
Calcium ion in skeletal muscle: its crucial role for muscle function, plasticity, and disease.
Physiol Rev
80:
1215-1265,
2000
3.
Batkai, S,
Racz IB,
Ivanics T,
Toth A,
Hamar J,
Slaaf DW,
Reneman RS,
and
Ligeti L.
An in vivo model for studying dynamics of intracellular free calcium changes in slow- and fast-twitch muscle fibers.
Pflügers Arch
440:
312-318,
2000.
4.
Baylor, SM,
and
Hollingworth S.
Fura-2 calcium transients in frog skeletal muscle fibers.
J Physiol
403:
151-192,
1988
5.
Baylor, SM,
and
Hollingworth S.
Model of sarcomeric Ca2+ movements, including ATP Ca2+ binding and diffusion, during activation of frog skeletal muscle.
J Gen Physiol
112:
297-316,
1998
6.
Becker, PL,
and
Fay FS.
Photobleaching of fura-2 and its effect on determination of calcium concentrations.
Am J Physiol Cell Physiol
253:
C613-C618,
1987
7.
Brozinick, JT, Jr,
Reynolds TH,
Dean D,
Cartee GD,
and
Cushman SW.
1-[N,O-bis-(5-isoquinolinesulphonyl)-N-methyl-L-tyrosil] -4-phenyl-piperazine (KN-62), an inhibitor of calcium-dependent calmodulin protein kinase II, inhibits both insulin- and hypoxia-stimulated glucose transport in skeletal muscle.
Biochem J
339:
533-540,
1999.
8.
Bruton, JD,
Katz A,
and
Westerblad H.
Insulin increases near-membrane but not global Ca2+ in isolated skeletal muscle.
Proc Natl Acad Sci USA
96:
3281-3286,
1999
9.
Carroll, SL,
Klein MG,
and
Schneider MF.
Calcium transients in intact rat skeletal muscle fibers in agarose gel.
Am J Physiol Cell Physiol
269:
C28-C34,
1995
10.
Cartee, GD,
Douen AG,
Ramlal T,
Klip A,
and
Holloszy JO.
Stimulation of glucose transport in skeletal muscle by hypoxia.
J Appl Physiol
70:
1593-1600,
1991
11.
Cartee, GD,
and
Holloszy JO.
Exercise increases susceptibility of muscle glucose transport to activation by various stimuli.
Am J Physiol Endocrinol Metab
258:
E390-E393,
1990
12.
Chance, B,
Choen P,
Jobsis F,
and
Shoener B.
Intracellular oxidation-reduction states in vivo.
Science
137:
499-508,
1962
13.
Chance, B,
and
Shoener B.
Correlation of oxidation-reduction changes of intracellular reduced pyridine nucleotide and changes in electroencephalogram of the rat in anoxia.
Nature
195:
956-958,
1962[Medline].
14.
Clapham, DE.
Calcium signaling.
Cell
80:
259-268,
1995[Web of Science][Medline].
15.
Du, GG,
Imredy JP,
and
MacLennan DH.
Characterization of recombinant rabbit cardiac and skeletal muscle Ca2+ release channels (ryanodine receptors) with a novel [3H]ryanodine binding assay.
J Biol Chem
273:
33259-33266,
1998
16.
Fischman, DA.
The synthesis and assembly of myofibrils in embryonic muscle.
Curr Top Dev Biol
5:
235-280,
1970[Medline].
17.
Garthwaithe, SM,
and
Holloszy JO.
Increased permeability to sugar following muscle contraction. Inhibitors of protein synthesis prevent reversal of the increase in 3-methylglucose transport rate.
J Biol Chem
257:
5008-5012,
1982
18.
Greco-Perotto, R,
Wertheimer E,
Jeanrenaud B,
Cerasi E,
and
Sasson S.
Glucose regulates its transport in L8 myocytes by modulating cellular trafficking of the transporter GLUT-1.
Biochem J
286:
157-163,
1992.
19.
Grynkiewicz, G,
Poenie M,
and
Tsien R.
A new generation of Ca2+ indicators with greatly improved fluorescence properties.
J Biol Chem
260:
3440-3450,
1985
20.
Hayashi, H,
Hirshman MF,
Kurth EJ,
Winder WW,
and
Goodyear LJ.
Evidence for 5' AMP-activated protein kinase mediation of the effect of muscle contraction on glucose transport.
Diabetes
47:
1369-1373,
1998[Abstract].
21.
Hesketh, TR,
Smith GA,
Moore JP,
Taylor MV,
and
Metcalfe JC.
Free cytoplasmic calcium concentration and the mitogenic stimulation of lymphocytes.
J Biol Chem
258:
4876-4882,
1983
22.
Holloszy, JO,
and
Narahara HT.
Studies of tissue permeability. X. Changes in permeability to 3-methylglucose associated with contraction of isolated frog muscles.
J Biol Chem
240:
3493-3500,
1965
23.
Holloszy, JO,
and
Hansen PA.
Regulation of glucose transport into skeletal muscle.
Rev Physiol Biochem Pharmacol
128:
99-193,
1996[Web of Science][Medline].
24.
Klein, MG,
Simon BJ,
and
Schneider MF.
Effects of procaine and caffeine on calcium release from the sarcoplasmic reticulum in frog skeletal muscle.
J Physiol
453:
341-366,
1992
25.
Konishi, M,
Olson A,
Hollingworth S,
and
Baylor SM.
Myoplasmic binding of fura-2 investigated by steady-state fluorescence and absorbance measurements.
Biophys J
54:
1089-1104,
1988[Web of Science][Medline].
26.
Konishi, M,
Hollingworth S,
Harkins AB,
and
Baylor SM.
Myoplasmic calcium transients in intact frog skeletal muscle fibers monitored with the fluorescent indicator furaptra.
J Gen Physiol
97:
271-301,
1991
27.
Konishi, M.
Cytoplasmic free concentrations of Ca2+ and Mg2+ in skeletal muscle fibers at rest and during contraction.
Jpn J Physiol
48:
421-438,
1998[Web of Science][Medline].
28.
Laughlin, MH,
Schaefer ME,
and
Sturek M.
Effect of exercise training on intracellular free Ca2+ transients in ventricular myocytes of rats.
J Appl Physiol
73:
1441-1448,
1992
29.
Liu, C,
and
Hermann TE.
Characterization of ionomycin as a calcium ionophore.
J Biol Chem
253:
5892-5894,
1978
30.
Lorenzon, P,
Grohovaz F,
and
Ruzzier F.
Voltage- and ligand-gated ryanodine receptors are functionally separated in developing C2Cl2 mouse myotubes.
J Physiol
525:
499-507,
2000
31.
Melzer, W,
Herrmann-Frank A,
and
Luttgau HC.
The role of Ca2+ ions in excitation-contraction coupling of skeletal muscle fibres.
Biochim Biophys Acta
1241:
59-116,
1995[Medline].
32.
Moore, EDW,
Becker PL,
Fogarty KF,
Williams DA,
and
Fay FS.
Ca2+ imaging in single living cells: theoretical and practical issues.
Cell Calcium
11:
157-179,
1990[Web of Science][Medline].
33.
Mu, J,
Brozinick JT, Jr,
Valladares O,
Bucan M,
and
Birnbaum MJ.
A role for AMP-activated protein kinase in contraction- and hypoxia-regulated glucose transport in skeletal muscle.
Mol Cell
7:
1085-1094,
2001[Web of Science][Medline].
34.
Nesher, R,
Karl IE,
Kaise KE,
and
Kipnis DM.
Epitrochlearis muscle. I. Mechanical performance, energetics, and fiber composition.
Am J Physiol Endocrinol Metab
239:
E454-E460,
1980
35.
Palmer, BM,
Thayer AM,
Snyder SM,
and
Moore RL.
Shortening and [Ca2+] dynamics of left ventricular myocytes isolated from exercise-trained rats.
J Appl Physiol
85:
2159-2168,
1998
36.
Plade, P.
Drug-induced Ca2+ release from isolated sarcoplasmic reticulum. II. Release involving a Ca2+-induced Ca2+ release channel.
J Biol Chem
262:
6142-6148,
1987
37.
Sato, K,
Ozaki H,
and
Karaki H.
Changes in cytosolic calcium level in vascular smooth muscle strip measured simultaneously with contraction using fluorescent calcium indicator fura 2.
J Pharmacol Exp Ther
246:
294-300,
1988
38.
Scanlon, M,
Williams DA,
and
Fay FS.
A Ca2+-insensitive form of fura-2 associated with polymorphonuclear leukocytes.
J Biol Chem
262:
6308-6312,
1987
39.
Schneider, MF,
and
Simon BJ.
Inactivation of calcium release from the sarcoplasmic reticulum in frog skeletal muscle.
J Physiol
405:
727-745,
1988
40.
Suda, N,
and
Kurihara S.
Intracellular calcium signals measured with fura-2 and aequorin in frog skeletal muscle fibers.
Jpn J Physiol
41:
277-295,
1991[Web of Science][Medline].
41.
Tabata, I,
Schluter J,
Gulve EA,
and
Holloszy JO.
Lithium increases susceptibility of muscle glucose transport to stimulation by various agents.
Diabetes
43:
903-907,
1994[Abstract].
42.
Tong, J,
Oyamada H,
Demaurex N,
Grinstein S,
McCarthy TV,
and
MacLennan DH.
Caffeine and halothane sensitivity of intracellular Ca2+ release is altered by 15 calcium release channel (ryanodine receptor) mutations associated with malignant hyperthermia and/or central core disease.
J Biol Chem
272:
26332-26339,
1997
43.
Tòth, A,
Ivanics T,
Ruttner Z,
Slaaf DW,
Reneman RS,
and
Ligeti L.
Quantitative assessment of [Ca2+]i levels in rat skeletal muscle in vivo.
Am J Physiol Heart Circ Physiol
275:
H1652-H1662,
1998
44.
Van Winkle, WB.
Calcium release from skeletal muscle sarcoplasmic reticulum: site of action of dantrolene sodium.
Science
193:
1130-1131,
1976
45.
Youn, JH,
Gulve EA,
and
Holloszy JO.
Calcium stimulates glucose transport in skeletal muscle by a pathway independent of contraction.
Am J Physiol Cell Physiol
260:
C555-C561,
1991
46.
Youn, JH,
Gulve EA,
Henriksen EJ,
and
Holloszy JO.
Interactions between effects of W-7, insulin, and hypoxia on glucose transport in skeletal muscle.
Am J Physiol Regul Integr Comp Physiol
267:
R888-R894,
1994
47.
Young, DA,
Uhl JJ,
Cartee GD,
and
Holloszy JO.
Activation of glucose transport in skeletal muscle by prolonged exposure to insulin: effects of glucose and insulin concentration.
J Biol Chem
261:
16049-16053,
1986
This article has been cited by other articles:
![]() |
K. Funai and G. D. Cartee Inhibition of Contraction-Stimulated AMP-Activated Protein Kinase Inhibits Contraction-Stimulated Increases in PAS-TBC1D1 and Glucose Transport Without Altering PAS-AS160 in Rat Skeletal Muscle Diabetes, May 1, 2009; 58(5): 1096 - 1104. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J. Rose, T. J. Alsted, T. E. Jensen, J. B. Kobbero, S. J. Maarbjerg, J. Jensen, and E. A. Richter A Ca2+-calmodulin-eEF2K-eEF2 signalling cascade, but not AMPK, contributes to the suppression of skeletal muscle protein synthesis during contractions J. Physiol., April 1, 2009; 587(7): 1547 - 1563. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Raney and L. P. Turcotte Evidence for the involvement of CaMKII and AMPK in Ca2+-dependent signaling pathways regulating FA uptake and oxidation in contracting rodent muscle J Appl Physiol, May 1, 2008; 104(5): 1366 - 1373. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Sonobe, T. Inagaki, D. C. Poole, and Y. Kano Intracellular calcium accumulation following eccentric contractions in rat skeletal muscle in vivo: role of stretch-activated channels Am J Physiol Regulatory Integrative Comp Physiol, April 1, 2008; 294(4): R1329 - R1337. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. F. Kramer, E. B. Taylor, C. A. Witczak, N. Fujii, M. F. Hirshman, and L. J. Goodyear Calmodulin-Binding Domain of AS160 Regulates Contraction- but Not Insulin-Stimulated Glucose Uptake in Skeletal Muscle Diabetes, December 1, 2007; 56(12): 2854 - 2862. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. C. Wright, P. C. Geiger, D.-H. Han, T. E. Jones, and J. O. Holloszy Calcium Induces Increases in Peroxisome Proliferator-activated Receptor {gamma} Coactivator-1{alpha} and Mitochondrial Biogenesis by a Pathway Leading to p38 Mitogen-activated Protein Kinase Activation J. Biol. Chem., June 29, 2007; 282(26): 18793 - 18799. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. E. Jensen, A. J. Rose, S. B. Jorgensen, N. Brandt, P. Schjerling, J. F. P. Wojtaszewski, and E. A. Richter Possible CaMKK-dependent regulation of AMPK phosphorylation and glucose uptake at the onset of mild tetanic skeletal muscle contraction Am J Physiol Endocrinol Metab, May 1, 2007; 292(5): E1308 - E1317. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J. Rose and E. A. Richter Skeletal Muscle Glucose Uptake During Exercise: How is it Regulated? Physiology, August 1, 2005; 20(4): 260 - 270. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Jessen and L. J. Goodyear Contraction signaling to glucose transport in skeletal muscle J Appl Physiol, July 1, 2005; 99(1): 330 - 337. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. C. Wright, P. C. Geiger, J. O. Holloszy, and D.-H. Han Contraction- and hypoxia-stimulated glucose transport is mediated by a Ca2+-dependent mechanism in slow-twitch rat soleus muscle Am J Physiol Endocrinol Metab, June 1, 2005; 288(6): E1062 - E1066. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. C. Wright, K. A. Hucker, J. O. Holloszy, and D. H. Han Ca2+ and AMPK Both Mediate Stimulation of Glucose Transport by Muscle Contractions Diabetes, February 1, 2004; 53(2): 330 - 335. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Terada and I. Tabata Effects of acute bouts of running and swimming exercise on PGC-1{alpha} protein expression in rat epitrochlearis and soleus muscle Am J Physiol Endocrinol Metab, February 1, 2004; 286(2): E208 - E216. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |